How should laboratories compare Epithalon price Australia on a per-milligram basis?
A usable comparison starts from the same reporting basis. Suppliers may quote a vial, a labelled milligram amount, or a purity-adjusted peptide mass; those figures are not interchangeable. The labelled milligram amount on a lyophilised vial is typically the gross solid as weighed after purification and drying, comprising peptide, counterion, residual moisture and residual solvents. Dividing a vial price by labelled milligrams therefore yields a gross-solid unit cost, not a peptide-backbone unit cost. When two Australian quotes differ by twenty or thirty percent, the first diagnostic is whether both vendors report the same basis.
Convert every quote to a documented peptide milligram. Read the lot CoA in parallel for labelled content, RP-HPLC purity as area percent at a stated wavelength, net peptide content by elemental or amino-acid analysis where provided, and water by Karl Fischer. A lot at 98% HPLC purity with 75% net peptide content delivers less peptide per labelled milligram than a lot at 97% HPLC purity with 85% net peptide content; the cheaper sticker can be the more expensive peptide.
Local Australian stock with tracked dispatch belongs in the unit-cost model because the receiving laboratory can reconcile the vial lot number against the CoA on arrival. Quotes that omit lot-linked chromatograms, mass spectra or a unique batch identifier are incomplete specifications, not discounted research-grade material. For AEDG, synthetic accessibility is high, so price dispersion usually reflects documentation depth, purification cut-points and assay completeness. Published overviews treat the tetrapeptide as a defined Ala-Glu-Asp-Gly sequence rather than a proprietary mixture (PMID:40141333), which is why a trade-name price without sequence confirmation is not a like-for-like bid. Compare dollars per documented peptide milligram only when sequence, salt form, CoA fields and lot identity match.
Which HPLC purity and related-substance fields change quoted AEDG cost?
Reversed-phase HPLC is the usual purity basis on research-peptide CoAs and a primary cost driver. Crude tetrapeptide after solid-phase assembly is inexpensive relative to method development, fraction cutting, re-analysis and rejection of off-specification pools. A specification of ≥95% area percent versus ≥98% or ≥99% at 214 nm or 220 nm changes how tightly the preparative cut can be taken and how much product is discarded. A 95% quote and a 99% quote are different purification endpoints, not the same material at different mark-ups.
Ask how purity was integrated. Peak-purity assessment with a diode-array detector (DAD), a stated peak threshold, and an identified main-peak retention time is not equivalent to a single-wavelength trace with undocumented integration. Related-substance reporting—deletion sequences, incomplete deprotection products, and aspartimide or racemisation-related species typical of Asp- and Glu-containing sequences—requires gradient resolution and longer run times. Those choices consume instrument time and reduce isolated yield. If the CoA reports only "purity 99%" without wavelength, column chemistry, gradient or a chromatogram, the number cannot be audited.
System-suitability data (theoretical plates, tailing factor, resolution to a neighbouring impurity, injection-sequence blanks) indicate whether the purity figure is a measurement or a screenshot. Orthogonal confirmation by a second HPLC condition or LC–MS extracted-ion review of the main peak reduces the risk that a co-eluting impurity is counted as AEDG. Short tetrapeptides are prone to co-elution on steep gradients. Literature on regulatory peptides treats short sequences as chemically defined species whose experimental interpretation depends on intact primary structure (PMID:14666197). Specify wavelength, area-percent limit, impurity reporting threshold and lot-linked chromatograms; those clauses explain much of the spread in milligram quotes once salt form is held constant.
How do net peptide content and counterion assays alter true milligram price?
HPLC area percent does not equal milligrams of peptide in the vial. Counterion and water occupy mass. AEDG contains two carboxylic acids (Glu, Asp) and an N-terminal amine, so it is commonly isolated as a TFA salt after preparative HPLC in fluorinated mobile phases, or exchanged to acetate. Residual TFA at 10–20% w/w is not unusual for unexchanged short peptides; acetate lots can look more expensive per labelled milligram until net peptide content is normalised. Karl Fischer water similarly inflates labelled mass. Without those assays, a per-mg Australian price is a price per unknown solid.
Net peptide content is typically estimated by nitrogen elemental analysis, quantitative amino-acid analysis after hydrolysis, or a calibrated UV assay against a qualified reference. Amino-acid analysis also supports composition (Ala, Glu, Asp, Gly in equimolar ratio), independent evidence that the solid is AEDG rather than a co-eluting deletion peptide. Laboratories that skip net-content testing and then prepare gravimetric solutions introduce a silent concentration bias into later chromatograms.
Counterion identity should be stated. TFA and acetate differ in UV background, ESI-MS ionisation behaviour and hygroscopicity. A CoA that reports "TFA salt" without a quantitative TFA value, or "acetate" without ion chromatography or NMR, leaves a mass-balance gap. When comparing quotes, compute peptide milligrams as labelled mass × net peptide fraction; if net content is absent, treat the quote as non-comparable. Physicochemical studies have described short regulatory peptides as sequence-dependent DNA-binding species in laboratory systems (PMID:15990728), a reminder that the chemical entity, including salt form, must match the intended oligopeptide. Counterion and water data are identity control, not a packaging upsell.
What mass-spectrometric identity evidence should an AEDG CoA include?
Price without identity is not a research specification. For Ala-Glu-Asp-Gly, electrospray ionisation mass spectrometry (ESI-MS) should report a molecular ion consistent with the monoisotopic mass of the free tetrapeptide (C14H22N4O9; 390.14 Da) plus observed adducts, typically [M+H]+ near m/z 391. Unit-resolution or high-resolution data with a stated instrument type belong on the CoA, together with the spectrum or a peak list. MALDI-TOF is acceptable as a complementary molecular-weight check but does not replace chromatographic purity. Request theoretical mass, observed m/z and the ion assignment on the same page as the purity chromatogram so goods-in staff can complete one identity check.
Sequence-level evidence is the next cost tier. Tandem MS (MS/MS) b- and y-ion series can confirm residue order, distinguishing AEDG from permutations or truncations of similar mass. Amino-acid analysis supports composition but not order. Experimental cell-line reports that employ this tetrapeptide are interpretable only if the test article matches the published sequence (PMID:40908429). The same requirement applies to laboratory embryology systems that specify the tetrapeptide as a defined reagent (PMID:39788414): the milligram price must buy documented identity.
Look also for appearance (white to off-white lyophilised solid), a solubility note for analytical reconstitution, and a batch number matching the vial. If a quote sits substantially below documented Australian lots, inspect whether ESI-MS, HPLC chromatograms and a unique lot code are included. Omitting those items is the usual source of an attractive headline price. Identity testing is the difference between purchasing AEDG and purchasing an unassigned solid.
How do lot-linked CoA packages affect Australian research procurement cost?
The documentation package is a priced deliverable. A complete Australian research pack typically includes lot number and release date; sequence and molecular formula; HPLC method summary (column, wavelength, gradient); chromatogram with integrated area-percent purity; MS spectrum with assigned molecular ion; net peptide content and/or elemental analysis; water; counterion; appearance; and a statement that the material is supplied for laboratory research use only. Generating, reviewing and archiving those records has a labour cost that cannot be removed without converting the quote into an undocumented chemical.
Lot linkage makes the pack usable. The vial label, the CoA header and the chromatogram file name should carry the same batch code. Multi-vial orders drawn from one lot allow a single HPLC–MS package to cover every container, improving the documentation-inclusive milligram price relative to mixed lots that each need a separate release. Incoming-identity checks should budget for that shared-lot structure when a low per-vial offer is actually many lots.
Australian local stock and tracked dispatch reduce the hidden cost of mismatched paperwork. When the parcel, the invoice and the CoA arrive together, goods-in inspection can reject discrepancies before the material enters laboratory inventory. Overseas catalogue prices that look lower often exclude time spent chasing missing spectra or discarding a lot that cannot be reconciled. Those hours belong in the true Epithalon price Australia comparison. Certificates should not imply therapeutic status. Literature describing the tetrapeptide in molecular and cell-based experimental systems (PMID:40141333; PMID:40908429) does not convert a research reagent into a registered good. The buyer is paying for traceable chemistry—identity, purity, content and auditable records—and that is the correct basis for accepting or rejecting a price.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
Is a lower Epithalon price Australia quote always better laboratory value?
No. A lower sticker usually omits net peptide content, counterion, water, chromatograms or MS assignment. Convert every bid to dollars per documented peptide milligram, holding salt form, HPLC wavelength and lot-linked CoA fields constant. Incomplete specifications are not equivalent research-grade material and should not be averaged into a market price.
Does HPLC area-percent purity equal the milligrams of AEDG in the vial?
No. HPLC area percent describes the main peak relative to integrated related substances at a stated wavelength. Counterion and water still occupy labelled mass. Use net peptide content and Karl Fischer water to convert labelled milligrams into peptide milligrams before any Australian per-mg comparison.
Which CoA fields should match the vial label before a quote is accepted?
Lot number, sequence (Ala-Glu-Asp-Gly / AEDG), labelled content, appearance and the research-use-only statement should match the vial. The HPLC chromatogram and MS spectrum should carry the same batch code. Mismatched identifiers mean the quoted price does not correspond to the container received and the lot should be queried before release into inventory.
Why do TFA and acetate AEDG lots quote differently per milligram?
Trifluoroacetate remaining from preparative HPLC can contribute a substantial mass fraction, so labelled milligrams overstate peptide content relative to an acetate-exchanged lot. Normalise both quotes by net peptide content and a quantitative counterion assay before concluding that one Australian milligram price is higher. Salt form should be an explicit line item on the quote.
Are overseas catalogue prices comparable to Australian local-stock quotes?
Only after documentation and fulfilment are equalised. Local stock with tracked dispatch lets goods-in staff reconcile lot codes on arrival. Overseas headlines that omit lot-linked HPLC–MS files shift labour and rejection risk onto the laboratory, and that labour belongs in the true unit cost even when the catalogue sticker is lower.
What identity tests distinguish AEDG from a permutation or truncation?
ESI-MS confirms molecular mass against C14H22N4O9; tandem MS b- and y-ions confirm residue order; amino-acid analysis confirms composition but not order. Combined with RP-HPLC purity at a stated wavelength, those tests are the minimum identity package that a research milligram price should buy. A trade name alone is not identity.
References
- PMID:40141333 — Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — Int J Mol Sci — 2025
- PMID:40908429 — Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Biogerontology — 2025
- PMID:39788414 — Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development — Life Sci — 2025
- PMID:14666197 — Effect of regulatory peptides on gene transcription — Bull Exp Biol Med — 2003
- PMID:15990728 — DNA double-helix binds regulatory peptides similarly to transcription factors — Neuro Endocrinol Lett — 2005
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
